Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2018-2023
Historical Year
2024-2032
Forecast Year
Global Female Sexual Dysfunction Treatment Market: Competitor Landscape
In September 2023, Biozeus Pharmaceutical S.A., an emerging clinical stage biopharmaceutical company based out of Brazil made significant strides in developing a topical treatment for female sexual dysfunction treatment disorder. Aphra, based on a new drug class BZ371 platform, exhibits a distinctive mechanism of local vasodilation and increased local blood flow, without any systemic exposure or side effects. The medication showed positive, safe, and tolerable results in Phase I clinical trials and was advanced to critical Phase II trials. With companies actively increasing their investments on research related activities and new drug development, the market is expected to witness the advent of several effective drugs in the forecast period.
The key features of the female sexual dysfunction treatment market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- AMAG Pharmaceuticals Inc.
- Emotional Brain BV
- Sprout Pharmaceuticals, Inc.
- Pivot Pharmaceuticals Inc.
- Apricus Biosciences, Inc.
- GlaxoSmithKline, Plc
- Pfizer, Inc.
- Merck & Co., Inc.
- Cipla Inc
- Duchesnay Inc.
- Novo Nordisk AS
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Female Sexual Dysfunction Treatment Market Report Snapshots
Female Sexual Dysfunction Treatment Market Size
Female Sexual Dysfunction Treatment Market Regional Analysis
Female Sexual Dysfunction Treatment Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The market is anticipated to grow at a CAGR of 34.2% during the forecast period of 2024-2032, likely to be driven by the increasing incidence of an aging female population across the globe.
The market demand is driven by rapid technological advancements, rising investment in research related activities and drug development, along with growing acceptance of alternative therapies for treating the condition.
The advent of smart devices to facilitate effective solutions to patients is a major market trend. One such example is ‘The Lioness Vibrator 2.0’ which has been developed by a United States based femtech start-up and helps women understand their arousal and sexual response based on data from pelvic muscle contractions.
Based on indication, the market is divided into hypoactive sexual desire disorder (HSDD), arousal disorder, penetration (sexual pain) disorder, and female orgasmic disorder, among others.
Counselling and behavioural therapy, medications, among others are the common treatments available in the market. Medications are divided into non-hormonal therapy and hormonal therapy.
Based on age group, the market is segmented into 18-30 years, 30-45 years, and above 45 years.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are AMAG Pharmaceuticals Inc., Emotional Brain BV, Sprout Pharmaceuticals, Inc., Pivot Pharmaceuticals Inc., Apricus Biosciences, Inc., GlaxoSmithKline, Plc., Pfizer, Inc., Merck & Co., Inc., Cipla Inc., Duchesnay Inc., and Novo Nordisk AS.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Strategic Solutions for Informed Decision-Making
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
- Our Insights Store:
-
Industry Statistics
-
Procurement Insights
-
Consumer Insights
Our Offices
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124